دورية أكاديمية
A Comprehensive Correlation of Clinicopathologic Prognostic Factors in Malignant Adult Renal Tumors: A Single Institutional Study.
| العنوان: | A Comprehensive Correlation of Clinicopathologic Prognostic Factors in Malignant Adult Renal Tumors: A Single Institutional Study. |
|---|---|
| عنوان ترانسليتريتد: | A Comprehensive Correlation of Clinicopathologic Prognostic Factors in Malignant Adult Renal Tumors: A Single Institutional Study. |
| المؤلفون: | Ayesha SM; Pathology, Nizams Institute of Medical Sciences, TELANGANA, INDIA., Sivakumar S; Pathology, Nizams Institute of Medical Sciences, TELANGANA, INDIA., Devraj R; Urology, Nizams Institute of Medical Sciences, TELANGANA, INDIA., Shantappa R; Surgical Oncology, Nizams Institute of Medical Sciences, TELANGANA, INDIA., Ratnagiri R; Surgical Oncology, Nizams Institute of Medical Sciences, TELANGANA, INDIA., Konatam ML; Medical Oncology, Nizams Institute of Medical Sciences, TELANGANA, INDIA., Uppin SG; Pathology, Nizams Institute of Medical Sciences, TELANGANA, INDIA., Paul TR; Pathology, Nizams Institute of Medical Sciences, TELANGANA, INDIA., Uppin MS; Pathology, Nizams Institute of Medical Sciences, TELANGANA, INDIA. |
| المصدر: | Turk patoloji dergisi [Turk Patoloji Derg] 2024; Vol. 40 (1), pp. 45-55. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Türk Patoloji Derneği Country of Publication: Turkey NLM ID: 9440471 Publication Model: Print Cited Medium: Internet ISSN: 1309-5730 (Electronic) Linking ISSN: 10185615 NLM ISO Abbreviation: Turk Patoloji Derg Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: İstanbul : Türk Patoloji Derneği |
| مواضيع طبية MeSH: | Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/pathology, Adult ; Humans ; Young Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Prognosis ; Retrospective Studies ; Necrosis/pathology ; Neoplasm Staging |
| مستخلص: | Objective: To study the clinicopathologic prognostic parameters of malignant adult renal tumors as these have poor over-all survival (OS) and show frequent metastasis. Material and Methods: This was a retrospective analysis of the clinical and pathologic features of malignant renal tumors in adult patients from January 2011 to December 2020. All the tumors were studied with respect to age, clinical presentation, tumor type/subtype, histologic grade (WHO/ISUP grading system), TNM stage and presence of necrosis. Correlation of histopathologic features and survival analysis was done using Kaplan-Meier survival curves and Cox-regression analysis. Results: A total of 257 cases were included in the study period including 253 renal cell tumors of which clear cell renal cell carcinoma accounted for 69.3%. The age of the patients ranged from 20 to 87 years (median-52 years). The overall survival significantly reduced with increasing histologic grade, stage, and presence of necrosis. The comparison between the histological subtypes was not statistically significant. Univariate Cox-regression analysis found significant hazard ratio with increasing age, size, histologic grade (G4 vs G1), stage, and presence of necrosis. The correlation of OS with histological subtypes was not significant. Multivariate analysis also showed increased hazard ratio with increasing age, size, grade, and stage. However, the P-value was significant only for age. Conclusion: Clear cell renal cell carcinoma was the commonest type of adult renal tumor. Older age at presentation, larger tumor size, presence of necrosis, and higher histologic grade and stage were associated with poor prognosis in these patients. |
| References: | J Urol. 2009 Nov;182(5):2132-6. (PMID: 19758615) J Clin Oncol. 2018 Oct 29;:JCO2018790147. (PMID: 30372388) Indian J Cancer. 2016 Oct-Dec;53(4):572-574. (PMID: 28485354) Cancer. 2000 Aug 1;89(3):604-14. (PMID: 10931460) Indian J Cancer. 2016 Jan-Mar;53(1):114-7. (PMID: 27146757) Eur Urol. 2005 Oct;48(4):593-600. (PMID: 15964127) J Clin Oncol. 2005 Apr 20;23(12):2763-71. (PMID: 15837991) Arch Pathol Lab Med. 2009 Feb;133(2):189-200. (PMID: 19195963) Am J Surg Pathol. 2006 May;30(5):575-84. (PMID: 16699311) Br J Cancer. 2012 Jan 17;106(2):279-83. (PMID: 22166802) Arch Pathol Lab Med. 2013 Apr;137(4):531-40. (PMID: 23544942) Curr Urol. 2020 Jun;14(2):98-104. (PMID: 32774235) Indian J Med Res. 2014 Nov;140(5):624-9. (PMID: 25579143) BJU Int. 2009 Jan;103(2):165-70. (PMID: 18782313) Indian J Cancer. 2017 Oct-Dec;54(4):601-604. (PMID: 30082542) Am J Surg Pathol. 2013 Oct;37(10):1490-504. (PMID: 24025520) Clin Cancer Res. 2009 Feb 15;15(4):1170-6. (PMID: 19228722) Am J Surg Pathol. 2014 Dec;38(12):1588-602. (PMID: 25025441) J Urol. 2010 Apr;183(4):1309-15. (PMID: 20171681) Pathology. 2007 Oct;39(5):459-65. (PMID: 17886093) |
| تواريخ الأحداث: | Date Created: 20240118 Date Completed: 20240119 Latest Revision: 20240529 |
| رمز التحديث: | 20240529 |
| مُعرف محوري في PubMed: | PMC11129866 |
| DOI: | 10.5146/tjpath.2023.12849 |
| PMID: | 38235567 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1309-5730 |
|---|---|
| DOI: | 10.5146/tjpath.2023.12849 |